The Business & Financial Times on MSNOpinion
Reflections by S.M.A: When greed grips growth: Confronting corruption
In recent years, the narrative surrounding corruption in Ghana has shifted from isolated scandals to a systemic malaise with ...
(NYSE:MSM), (“MSC”, “MSC Industrial”, or the “Company,” “we”, “us”, or “our”) a leading North American distributor of a broad range of metalworking and maintenance, repair and operations (“MRO”) ...
The Grand Hyatt Singapore’s Muslim-friendly experience shows that “faith and five-star living can integrate effortlessly”, ...
For shoppers and diners, the Hong Kong Tourism Board will link with industry partners to launch a WinterFest Delights ...
Euronext announces tender offer on existing EUR 2026 Bonds and intention to launch a new bonds issuance Amsterdam, Brussels, ...
BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter ...
On 25 November, I will be a guest of Babcock University to deliver a “send-forth” lecture in honor of Professor Ademola, who ...
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / November 6, 2025 / Goldgroup Mining Inc. (“Goldgroup” or the “Company”) (TSXV:GGA)(OTCQX:GGAZF) is pleased to announce that it has filed an updated NI ...
RACINE, Wis., Nov. 01, 2025 (GLOBE NEWSWIRE) -- How do small mistakes in estate planning cause major probate delays? In an article featured in HelloNation, Attorney Andrew Rosenberg of Knuteson, ...
BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
DENVER (KDVR) — Colorado Parks and Wildlife received a letter this month from the U.S. Fish and Wildlife Service, informing the state agency that it could not source gray wolves for reintroduction to ...
Gene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today reported additional preliminary data from the pivotal cohort of its ongoing, Phase 2 LEGEND trial of detalimogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results